Micardis is manufactured by Boehringer Ingelheim.
Micardis is part of a class of drugs called angiotensin II receptor blockers, or ARBs for short. Micardis blocks angiotensin II receptors (hence its classification as an angiotensin II receptor blocker). This decreases the effectiveness of a chemical known as angiotensin II, which normally causes blood vessels to narrow (constrict). By blocking the effects of angiotensin II, Micardis causes blood vessels to relax, which can
lower blood pressure.
A
blood pressure reading consists of two numbers -- for example: 120/80. The top number is known as the
systolic blood pressure, and the bottom number is the
diastolic blood pressure. During clinical studies in people taking Micardis 80 mg, systolic
blood pressure (the top number) decreased, on average, by 12 to 13 mmHg and diastolic blood pressure (the bottom number) decreased by 7 to 8 mmHg, on average. Lower doses of Micardis resulted in a smaller drop in blood pressure.